KU Wichita Internal Medicine is currently having two COVID Trials. SCORPIO-PEP: This is a 28-day study to assess the prevention of COVID-19 infection in those who have been exposed through household contact. Both individuals with COVID-19 and those who live in the same household as someone with COVID-19 can participate in the SCORPIO study.
37.3 million adults in the U.S. have some form of diabetes, and one in five are unaware they have it. This chronic disease is the seventh leading cause of death, but in the last 20 years, the number of adults with diabetes has doubled.
The University of Kansas School of Medicine-Wichita Center for Clinical Research has resumed leading the local effort of a nationwide clinical trial brought through the COVID-19 Prevention Network testing the COVID-19 vaccine AZD1222, developed by Oxford University and purchased by AstraZeneca.
KU Internal Medicine-Wichita has been honored with four Wichita Business Journal Healthcare Heroes Awards. We would like to recognize the following faculty members and departments for their dedication to helping others. Wichita Business Journal Health Care Heros Award Winners Contact KU Wichita Internal Medicine The internal medicine specialists at KU Wichita Internal Medicine are dedicated to providing the highest quality of care to patients throughout the Wichita,
Donna Sweet, MD, AAHIVS, MACP was inducted into the Wichita State University Fairmount College of Liberal Arts and Sciences Hall of Fame on Friday, Dec 6. Induction in to the Fairmount College of Liberal Arts and Sciences Hall of Fame is in recognition of an alum’s highly significant impact on the region and the nation.
High blood pressure increases your risk for dangerous health conditions like a stroke, a heart attack, kidney disease, and chronic heart failure. If that doesn’t give you the motivation to manage your blood pressure, this might.